{
    "Trade/Device Name(s)": [
        "Gmate\u00ae SMART Blood Glucose Monitoring System",
        "Gmate\u00ae Blood Glucose Test Strips",
        "Gmate\u2122 SMART App"
    ],
    "Submitter Information": "Philosys Inc.",
    "510(k) Number": "K150299",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131230"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JQP"
    ],
    "Summary Letter Date": "November 11, 2015",
    "Summary Letter Received Date": "November 12, 2015",
    "Submission Date": "February 3, 2015",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.2100"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Gmate\u00ae SMART meter",
        "Apple iOS devices",
        "Android devices"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical",
        "Glucose oxidase method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "App",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Gmate\u00ae SMART Blood Glucose Monitoring System including meter, test strips, app, and control material for use with iOS and Android devices for quantitative glucose measurement.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from various body sites by a single person for self-testing at home to monitor diabetes management; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}